Across all EpCAM+ tumor cell lines, the EpCAM/CD16A ICE® exhibited the highest potency, and the EpCAM/NKp46 ICE® and anti-EpCAM Fc-enhanced IgG1 had potencies falling in the similar concentration range (Table 7). The gene discussed is NCR1; the disease is neoplasm.